文献速递结核与非结核分枝杆菌

FluoroType MTBDR 检测肺及肺外样本中结核分枝杆菌复合群

Detection of Mycobacterium tuberculosis complex in pulmonary and extrapulmonary samples with the FluoroType MTBDR assay.
PubMed 文献 · Clin Microbiol Infect · 2021-01-06

研究评估 FluoroType MTBDR 实时 PCR 在单次反应中同时检测 MTBC 及 INH/RIF 耐药突变的可行性,分析 3885 份连续原代样本并与镜检和培养比较。总体灵敏度 0.714、特异度 0.996,痰标本灵敏度 0.854;139 份 MTBC 阳性中 99 份(71%)至少一种药物获得可解释耐药结果。

要点

  • FT-MTBDR 单次 PCR 可同时检测 MTBC 及 INH/RIF 耐药突变
  • 痰标本灵敏度 0.854,总体灵敏度 0.714,特异度 0.996
  • MTBC 阳性中 71% 至少一种药物获得可解释基因型耐药结果

核心结论

  • FT-MTBDR 检测 MTBC 能力 adequate,并具有单次 PCR 同时检测 INH 和 RIF 基因型耐药的显著附加特征。

研究设计与样本

  • 连续分析 3885 份原代样本,其中痰 978 份、其他呼吸道部位加胃灌洗液 2007 份、肺外部位 875 份,与镜检和培养比较。

主要发现

  • 176 份培养 MTBC 阳性,139 份 FT-MTBDR 阳性,灵敏度 0.714(95%CI 0.640-0.779),特异度 0.996(95%CI 0.994-0.998)。
  • 978 份痰中 96 份培养阳性、89 份 FT-MTBDR 阳性,灵敏度 0.854(95%CI 0.764-0.915),特异度 0.992(95%CI 0.983-0.997)。
  • 139 份 MTBC 阳性中,99 份(71%)至少一种药物获得可解释基因型耐药结果,92 份(66%)两种药物均获得。

临床怎么用

  • FT-MTBDR 可作为 MTBC 检测并同步提供 INH 和 RIF 耐药信息的单次 PCR 方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Rifampicin (RIF) and isoniazid (INH) are the two most effective first-line antibiotic drugs for the treatment of tuberculosis (TB). The new FluoroType MTBDR (FT-MTBDR) real-time PCR is intended to detect INH and RIF resistance mutations as a second step following a primary Mycobacterium tuberculosis complex (MTBC) PCR. Here we evaluate the feasibility of the FT-MTBDR assay to detect simultaneously MTBC-specific DNA as well as to detect potential INH and RIF resistance through analysing inhA promotor, katG and rpoB sequences in one PCR reaction. METHODS: We analysed 3885 consecutive primary samples with FT-MTBDR and compared the results with microscopy and culture: 978 were from sputum, 2007 from other respiratory tract locations plus gastric lavages, and 875 from extrapulmonary locations, respectively. RESULTS: Overall, 176 samples were MTBC culture positive and 139 FT-MTBDR positive, providing a FT-MTBDR sensitivity of 0.714 (95% confidence interval 0.640-0.779) and specificity of 0.996 (0.994-0.998), respectively. For the 978 sputum, 96 were MTBC culture positive and 89 FT-MTBDR positive, sensitivity 0.854 (0.764-0.915) and specificity 0.992 (0.983-0.997). Of the 139 MTBC positive, 99 (71%) had interpretable genotypic resistance results for at least one drug, 92 (66%) for both drugs. DISCUSSION: The ability of FT-MTBDR to detect MTBC is adequate with the significant added feature of simultaneous genotypic resistance detection of both INH and RIF in a single PCR reaction.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Svensson E, Folkvardsen DB, Rasmussen EM, et al. Detection of Mycobacterium tuberculosis complex in pulmonary and extrapulmonary samples with the FluoroType MTBDR assay. Clin Microbiol Infect. 2021. PMID: 33421581. doi:10.1016/j.cmi.2020.12.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。